GSK3B and diabetes mellitus: These results suggest that FGF1 administration may alleviate diabetes-induced suppression of BDNF via coordinately enhancing AKT-GSK3β-CREB (S133) signaling and inhibiting PERK-CREB (S129) signaling in hippocampus during DICD.